Evidence map›Paper›PMID 26380641›Full record

ArticleStandards in genomic sciences2015

High-Quality draft genome sequence of the Lotus spp. microsymbiont Mesorhizobium loti strain CJ3Sym.

Wayne Reeve, John Sullivan, Clive Ronson, Rui Tian, Christine Munk, Cliff Han, T B K Reddy, Rekha Seshadri, Tanja Woyke, Amrita Pati and 3 more

Abstract readCase Reports
In one paragraph

Article in Standards in genomic sciences, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Wayne ReeveCentre for Rhizobium Studies, Murdoch University, Perth, WA Australia.
John SullivanDepartment of Microbiology and Immunology, University of Otago, Dunedin, New Zealand.
Clive RonsonDepartment of Microbiology and Immunology, University of Otago, Dunedin, New Zealand.
Rui TianCentre for Rhizobium Studies, Murdoch University, Perth, WA Australia.
Christine MunkLos Alamos National Laboratory, Bioscience Division, Los Alamos, NM USA.
Cliff HanLos Alamos National Laboratory, Bioscience Division, Los Alamos, NM USA.
T B K ReddyDOE Joint Genome Institute, Walnut Creek, CA USA.
Rekha SeshadriDOE Joint Genome Institute, Walnut Creek, CA USA.
Tanja WoykeDOE Joint Genome Institute, Walnut Creek, CA USA.
Amrita PatiDOE Joint Genome Institute, Walnut Creek, CA USA.
Victor MarkowitzBiological Data Management and Technology Center, Lawrence Berkeley National Laboratory, Berkeley, CA USA.
Natalia IvanovaDOE Joint Genome Institute, Walnut Creek, CA USA.
Nikos KyrpidesDOE Joint Genome Institute, Walnut Creek, CA USA ; Department of Biological Sciences, King Abdulaziz University, Jeddah, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mesorhizobium loti strain CJ3Sym was isolated in 1998 following transfer of the integrative and conjugative element ICEMlSym(R7A), also known as the R7A symbiosis island, in a laboratory mating from the donor M. loti strain R7A to a nonsymbiotic recipient Mesorhizobium strain CJ3. Strain CJ3 was originally isolated from a field site in the Rocklands range in New Zealand in 1994. CJ3Sym is an aerobic, Gram-negative, non-spore-forming rod. This report reveals the genome of M. loti strain CJ3Sym currently comprises 70 scaffolds totaling 7,563,725 bp. The high-quality draft genome is arranged in 70 scaffolds of 71 contigs, contains 7,331 protein-coding genes and 70 RNA-only encoding genes, and is part of the GEBA-RNB project proposal.

Indexed as

AlphaproteobacteriaGEBA-RNBNitrogen fixationRoot-nodule bacteriaSymbiosis

Identifiers

PMID26380641
PMCPMC4572658

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.